EDIL3-DT

Across TCGA pan-cancer cohorts, EDIL3-DT RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated EDIL3-DT data layer.

The strongest signal is observed in mesothelioma (MESO), where higher EDIL3-DT RNA is associated with worse overall survival. In most high-consensus cancer types, elevated EDIL3-DT expression acts as an unfavorable survival marker, although some lineages such as KIRP and LGG show a favorable association.

MESO, STAD, and KIRP are the cancer types where EDIL3-DT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.422	0.676	<.001	85	view →
STAD	OS	Tertile	All	0.390	0.659	.004	40	view →
KIRP	DFS	Median	All	0.913	0.620	.006	28	view →
ACC	DFS	Median	All	0.542	0.896	.001	18	view →
UVM	DFS	Tertile	All	0.365	0.643	.026	14	view →
LGG	OS	Tertile	All	0.699	0.419	.010	13	view →
LUSC	DFS	Quartile	All	0.830	0.685	.004	12	view →
UCS	OS	Median	II,III,IV	0.570	0.239	.018	10	view →
PRAD	OS	Median	All	1.000	0.736	<.001	10	view →
SKCM	OS	Tertile	IV	0.890	0.326	.023	9	view →
COAD	OS	Median	IV	0.607	0.291	.012	9	view →
HNSC	DFS	Median	All	0.598	0.722	.018	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

EDIL3-DT–MESO (OS)

Open the MESO breakdown →